These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 38689291)

  • 21. CD73: an emerging checkpoint for cancer immunotherapy.
    Chen S; Wainwright DA; Wu JD; Wan Y; Matei DE; Zhang Y; Zhang B
    Immunotherapy; 2019 Aug; 11(11):983-997. PubMed ID: 31223045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual Mechanisms of Novel CD73-Targeted Antibody and Antibody-Drug Conjugate in Inhibiting Lung Tumor Growth and Promoting Antitumor Immune-Effector Function.
    Jin R; Liu L; Xing Y; Meng T; Ma L; Pei J; Cong Y; Zhang X; Ren Z; Wang X; Shen J; Yu K
    Mol Cancer Ther; 2020 Nov; 19(11):2340-2352. PubMed ID: 32943546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-BCMA surface engineered biomimetic photothermal nanomissile enhances multiple myeloma cell apoptosis and overcomes the disturbance of NF-κB signaling in vivo.
    Xiao X; Ma Z; Li Z; Deng Y; Zhang Y; Xiang R; Zhu L; He Y; Li H; Jiang Y; Zhu Y; Xie Y; Peng H; Liu X; Wang H; Ye M; Zhao Y; Liu J
    Biomaterials; 2023 Jun; 297():122096. PubMed ID: 37075614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Homotypic Membrane-Camouflaged Biomimetic Nanoplatform with Gold Nanocrystals for Synergistic Photothermal/Starvation/Immunotherapy.
    Li Z; Rong L
    ACS Appl Mater Interfaces; 2021 May; 13(20):23469-23480. PubMed ID: 33999610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Black porous silicon as a photothermal agent and immunoadjuvant for efficient antitumor immunotherapy.
    Xu W; Pang C; Song C; Qian J; Feola S; Cerullo V; Fan L; Yu H; Lehto VP
    Acta Biomater; 2022 Oct; 152():473-483. PubMed ID: 36087872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bifunctional black phosphorus quantum dots platform: Delivery and remarkable immunotherapy enhancement of STING agonist.
    Zhang Y; Wang S; Rha H; Xu C; Pei Y; Ji X; Zhang J; Lu R; Zhang S; Xie Z; Kim JS
    Biomaterials; 2024 Dec; 311():122696. PubMed ID: 38971121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tetradecanol-wrapped, CpG-loaded porous Prussian blue nanoimmunomodulator for photothermal-responsive in situ anti-tumor vaccine-like immunotherapy.
    Yin C; Xing Y; Zhao P; Yin Y; Yao H; Xue J; Gu W
    Biomater Adv; 2024 Nov; 164():213996. PubMed ID: 39146604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD73 as a potential opportunity for cancer immunotherapy.
    Ghalamfarsa G; Kazemi MH; Raoofi Mohseni S; Masjedi A; Hojjat-Farsangi M; Azizi G; Yousefi M; Jadidi-Niaragh F
    Expert Opin Ther Targets; 2019 Feb; 23(2):127-142. PubMed ID: 30556751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interference of ATP-Adenosine Axis by Engineered Biohybrid for Amplifying Immunogenic Cell Death-Mediated Antitumor Immunotherapy.
    Deng XC; Liang JL; Zhang SM; Wang YZ; Lin YT; Meng R; Wang JW; Feng J; Chen WH; Zhang XZ
    Adv Mater; 2024 Sep; 36(36):e2405673. PubMed ID: 39022876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulating immune memory and reversing tumor thermotolerance through a step-by-step starving-photothermal therapy.
    Luo L; Qin B; Jiang M; Xie L; Luo Z; Guo X; Zhang J; Li X; Zhu C; Du Y; Peng L; You J
    J Nanobiotechnology; 2021 Sep; 19(1):297. PubMed ID: 34593005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor Microenvironment-Regulating Immunosenescence-Independent Nanostimulant Synergizing with Near-Infrared Light Irradiation for Antitumor Immunity.
    Uthaman S; Pillarisetti S; Hwang HS; Mathew AP; Huh KM; Rhee JH; Park IK
    ACS Appl Mater Interfaces; 2021 Feb; 13(4):4844-4852. PubMed ID: 33486952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineering Bimetallic Polyphenol for Mild Photothermal Osteosarcoma Therapy and Immune Microenvironment Remodeling by Activating Pyroptosis and cGAS-STING Pathway.
    Liu K; Zan P; Li Z; Lu H; Liu P; Zhang L; Wang H; Ma X; Chen F; Zhao J; Sun W
    Adv Healthc Mater; 2024 Sep; 13(22):e2400623. PubMed ID: 38691766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy Strategy Targeting Programmed Cell Death Ligand 1 and CD73 with Macrophage-Derived Mimetic Nanovesicles to Treat Bladder Cancer.
    Zhou Q; Ding W; Qian Z; Zhu Q; Sun C; Yu Q; Tai Z; Xu K
    Mol Pharm; 2021 Nov; 18(11):4015-4028. PubMed ID: 34648293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of CD73 improves B cell-mediated anti-tumor immunity in a mouse model of melanoma.
    Forte G; Sorrentino R; Montinaro A; Luciano A; Adcock IM; Maiolino P; Arra C; Cicala C; Pinto A; Morello S
    J Immunol; 2012 Sep; 189(5):2226-33. PubMed ID: 22826317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD73 controls ocular adenosine levels and protects retina from light-induced phototoxicity.
    Losenkova K; Takeda A; Ragauskas S; Cerrada-Gimenez M; Vähätupa M; Kaja S; Paul ML; Schmies CC; Rolshoven G; Müller CE; Sandholm J; Jalkanen S; Kalesnykas G; Yegutkin GG
    Cell Mol Life Sci; 2022 Feb; 79(3):152. PubMed ID: 35212809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered purinergic signaling in CD73-deficient mice inhibits tumor progression.
    Yegutkin GG; Marttila-Ichihara F; Karikoski M; Niemelä J; Laurila JP; Elima K; Jalkanen S; Salmi M
    Eur J Immunol; 2011 May; 41(5):1231-41. PubMed ID: 21469131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracellular adenosine produced by ecto-5'-nucleotidase (CD73) regulates macrophage pro-inflammatory responses, nitric oxide production, and favors Salmonella persistence.
    Costales MG; Alam MS; Cavanaugh C; Williams KM
    Nitric Oxide; 2018 Jan; 72():7-15. PubMed ID: 29108754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of NIR therapy and regulatory T cell modulation using layer-by-layer hybrid nanoparticles for effective cancer photoimmunotherapy.
    Ou W; Jiang L; Thapa RK; Soe ZC; Poudel K; Chang JH; Ku SK; Choi HG; Yong CS; Kim JO
    Theranostics; 2018; 8(17):4574-4590. PubMed ID: 30279723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses.
    Young A; Ngiow SF; Barkauskas DS; Sult E; Hay C; Blake SJ; Huang Q; Liu J; Takeda K; Teng MWL; Sachsenmeier K; Smyth MJ
    Cancer Cell; 2016 Sep; 30(3):391-403. PubMed ID: 27622332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD73 blockade enhances the local and abscopal effects of radiotherapy in a murine rectal cancer model.
    Tsukui H; Horie H; Koinuma K; Ohzawa H; Sakuma Y; Hosoya Y; Yamaguchi H; Yoshimura K; Lefor AK; Sata N; Kitayama J
    BMC Cancer; 2020 May; 20(1):411. PubMed ID: 32397971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.